Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates.
Abstract | BACKGROUND: Candida species are the third most common cause of pediatric health care-associated bloodstream infection in the United States and Europe. To our knowledge, this report from the International Pediatric Fungal Network is the largest prospective, multicenter observational study dedicated to pediatric and neonatal invasive candidiasis. METHODS: RESULTS: CONCLUSIONS: We found a predominance of non-albicans Candida infection in children and similar outcomes based on antifungal class used. This international collaborative study sets the foundation for large epidemiologic studies focusing on the unique features of neonatal and pediatric candidiasis and comparative studies of therapeutic interventions in these populations.
|
Authors | William J Steinbach, Emmanuel Roilides, David Berman, Jill A Hoffman, Andreas H Groll, Ibrahim Bin-Hussain, Debra L Palazzi, Elio Castagnola, Natasha Halasa, Aristea Velegraki, Christopher C Dvorak, Arunaloke Charkabarti, Lillian Sung, Lara Danziger-Isakov, Catherine Lachenauer, Antonio Arrieta, Katherine Knapp, Mark J Abzug, Christine Ziebold, Thomas Lehrnbecher, Lena Klingspor, Adilia Warris, Kateri Leckerman, Teresa Martling, Thomas J Walsh, Daniel K Benjamin Jr, Theoklis E Zaoutis, International Pediatric Fungal Network |
Journal | The Pediatric infectious disease journal
(Pediatr Infect Dis J)
Vol. 31
Issue 12
Pg. 1252-7
(Dec 2012)
ISSN: 1532-0987 [Electronic] United States |
PMID | 22982980
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adolescent
- Antifungal Agents
(administration & dosage)
- Candida
(classification, isolation & purification)
- Candidiasis, Invasive
(drug therapy, epidemiology, microbiology)
- Child
- Child, Preschool
- Epidemiologic Studies
- Europe
(epidemiology)
- Female
- Humans
- Infant
- Infant, Newborn
- International Cooperation
- Male
- Prospective Studies
- Treatment Outcome
- United States
(epidemiology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|